Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In US, Does NDI Indicate ‘Not Delivering Innovation’ Rather Than ‘New Dietary Ingredient’?
Reasons Clear For Gridlock On FDA’s Notification Requirement, Solution Remains Murky
Jul 18 2021
•
By
Malcolm Spicer
More from Regulation
More from Policy & Regulation